The survey of more than 550 leading surgeons and theatre nurses in the UK, US, Japan and Scandinavia found 31% had personally experienced a skin reaction on their hands. A fifth (20%) said they had even been forced to change gloves during an operation on a patient due to an irritating and distracting reaction.

Shockingly, allergic reactions appear to be a widespread and common issue for many surgeons and nurses working to meet the unprecedented demands placed on elective care following the coronavirus pandemic. Of those affected, more than 9 in 10 (94.5%) experienced an allergic reaction on multiple occasions and 27% have experienced reactions more than 10 times in their career.

Reactions included dry and itchy skin, rashes and blisters. Of those who had experienced a skin reaction, one third (34%) said that it had a negative impact on their quality of life and work.

The survey also found:

• 11% of surgeons suffered an allergic reaction to equipment in the operating theatre once a week, whilst 63% suffered a reaction at least once a year.
• 41% respondents had experienced a reaction in the last six months, whilst over half (53%) had suffered a reaction in the past year.
• 2% reported they had been distracted from their work due to a skin reaction to surgical gloves.
• 84% of those who experienced a reaction were diagnosed with contact or allergic dermatitis, which is a response caused by contact with a substance.

The survey was conducted by SERMO for Mölnlycke^®, a world-leading medical solutions company which has developed Biogel^® UltraTouch^® S gloves, designed to minimise the risk of allergic and irritant contact dermatitis.

Rose Gallagher MBE, Professional Lead Infection Prevention and Control at Royal College of Nursing, commented:

“Wearing the right gloves and gloves only when required, as well as proper hand washing and moisturising with emollients, is vital to protecting the hands.

If we don’t look after our hands, we may not be able to look after our patients and ultimately risk long-term damage to our hands, which in some cases can result in life-long damage.”

Commenting on the survey findings, John Timmons, Clinical Staff Nurse and International Medical Director, said:

“This landmark survey demonstrates another unacceptable risk that surgeons and nurses are having to face whilst helping patients in hospitals around the world. With health systems across the globe under immense pressure to meet the demands of the coronavirus pandemic, healthcare professionals should not have to deal with blisters, rashes and itchy skin while trying to perform operations.”

“Mölnlycke’s purpose is to advance performance in healthcare across the world, and we aspire to equip everybody in healthcare with solutions to achieve the best outcomes. Recognising the high levels of allergic and contact dermatitis which surgeons and nurses face, we have developed the Biogel UltraTouch S, which has been designed to minimise the risk of allergic and irritant contact dermatitis. It is vital that hospitals recognise and provide for the dermatological requirements of each and every healthcare professional in the operating theatre.”

Find out more about the survey results at www.molnlycke.com/biogel.

NOTES TO EDITORS

The survey looked at the opinions and experiences of 568 leading surgeons and nurses across the United Kingdom, United States, Japan and Scandinavia.

Media enquiries

Please contact:

Will Culliford or Michael Latham, Lexington Communications
E: Molnlycke@lexcomm.co.uk
T: +44 20 7025 2300

OR

Katie Harrison, Mölnlycke Health Care
E: katie.harisson@molnlycke.com
T: +46 31 7223350

About SERMO

SERMO is the most trusted and preferred social network for doctors. It’s private and exclusively for doctors. SERMO is the meeting of medical minds and hearts. It’s a virtual doctors' lounge.

All of SERMO's over 800,000 members are verified and credentialised physicians. SERMO has also opened its doors to the global community, including physicians from 150 countries with plans for a continued global expansion. Find out more at www.sermo.com.